Marie Thibault

Stock Analyst at BTIG

(3.93)
# 671
Out of 4,734 analysts
75
Total ratings
54.29%
Success rate
9.67%
Average return

Stocks Rated by Marie Thibault

Inari Medical
Jan 8, 2025
Downgrades: Neutral
Price Target: n/a
Current: $79.55
Upside: -
Embecta
Nov 27, 2024
Upgrades: Buy
Price Target: $26
Current: $18.68
Upside: +39.19%
Insulet
Nov 8, 2024
Maintains: Buy
Price Target: $260$270
Current: $275.81
Upside: -2.11%
Masimo
Oct 14, 2024
Maintains: Buy
Price Target: $166$170
Current: $172.29
Upside: -1.33%
Establishment Labs Holdings
Oct 14, 2024
Maintains: Buy
Price Target: $62$65
Current: $34.56
Upside: +88.08%
Boston Scientific
Oct 14, 2024
Maintains: Buy
Price Target: $84$93
Current: $98.66
Upside: -5.74%
Haemonetics
Sep 10, 2024
Initiates: Buy
Price Target: $112
Current: $73.49
Upside: +52.40%
AtriCure
Jul 31, 2024
Maintains: Buy
Price Target: $58$53
Current: $38.47
Upside: +37.77%
DexCom
Jul 26, 2024
Maintains: Buy
Price Target: $156$120
Current: $84.38
Upside: +42.21%
Beyond Air
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.42
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $0.36
Upside: -
Maintains: Buy
Price Target: $19$20
Current: $14.31
Upside: +39.76%
Maintains: Buy
Price Target: $165$140
Current: $108.33
Upside: +29.23%
Maintains: Buy
Price Target: $4$3
Current: $1.97
Upside: +52.67%
Maintains: Buy
Price Target: $120$125
Current: $113.48
Upside: +10.15%
Maintains: Buy
Price Target: $9$7
Current: $2.24
Upside: +212.50%
Downgrades: Neutral
Price Target: n/a
Current: $2.46
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $0.85
Upside: -
Maintains: Buy
Price Target: $11$6
Current: $250.97
Upside: -97.61%